Navigation Links
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
Date:7/9/2008

SOUTH SAN FRANCISCO, July 9 /PRNewswire/ -- Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of noninfectious uveitis, a chronic and potentially sight-threatening inflammation of the eye. The randomized, double-masked, placebo-controlled study will evaluate the safety and efficacy of Simulect as maintenance therapy in 56 patients. During the study, patients will undergo tapering of concomitant immunosuppressive medications, the mainstay of treatments for noninfectious uveitis. This is the second mid-stage trial for basiliximab run by Cerimon, which began a Phase IIb study for patients with moderate-to-severe, steroid-refractory ulcerative colitis (UC) in April 2007.

"The initiation of this proof-of-concept study is part of our overall strategy to seek additional indications for already marketed drugs in areas with significant unmet medical needs," stated Paul Sekhri, President and CEO of Cerimon Pharmaceuticals. "In noninfectious uveitis, we believe Simulect has the potential to significantly improve the quality of life for patients by reducing adverse events often associated with oral or topical corticosteroids while maintaining effective control of their inflammation."

Basiliximab is a monoclonal antibody that selectively blocks the interleukin-2 (IL-2) receptor. This mechanism of action provides highly targeted inhibition of the T-lymphocyte activation that is involved in serious immune-related diseases including noninfectious uveitis. In February 2006, the Company licensed basiliximab from Novartis Pharma AG for the treatment of Inflammatory Bowel Disease (IBD) and initiated a Phase IIb clinical study for the treatment of moderate-to-severe, steroid-refractory ulcerative colitis the following year. In December 2007, Cerimon entered into an agreement with Novartis to conduct a proof-of-concept study for basiliximab for the treatment of noninfectiou
'/>"/>

SOURCE Cerimon Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
2. Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
3. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
4. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
7. Isis Pharmaceuticals Conference Call Notice
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...lif., Nov. 9 Asthmatx, Inc. presen...ng the effectiveness and safety of bronchial therm...ow this new procedure will impact allergy practice...l Meeting of the American College of Allergy, Asth..., The poster, titled "Where Could Bronchial Ther...
(Date:11/9/2009)..., Nov. 9 Boston Scientif...aunch of its COGNIS® cardiac resynchronizatio...implantable cardioverter defibrillator (ICD) in Ja...Ministry of Health, Labor and Welfare (MHLW) in Au...ber. COGNIS and TELIGEN are the result of a multi...
(Date:11/9/2009)... ISTA Pharmaceuticals, I...esults from the Company,s Bepreve(TM) (bepotastine...al studies. These results were presented in poste...can College of Allergy, Asthma & Immunology (A...ntation titled, "Treatment of Ocular Itching with ...
Breaking Medicine Technology:Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 2Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 3Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan 4ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Yes we have bananas 21 10321 1Onyx Pharmaceuticals Announces Investor Teleconference and Webcast 5369 1Canary Foundation Commits to Supporting New Platform for Cancer Diagnostics 59266 1Canary Foundation Commits to Supporting New Platform for Cancer Diagnostics 59266 2Canary Foundation Commits to Supporting New Platform for Cancer Diagnostics 59266 3
... ranged from 1.39 to 1.73, BOSTON, Oct. 26 Shire...al specialty biopharmaceutical company, today,anno...dexamfetamine,dimesylate) effect size. These findi...psychiatrists in Boston. Effect size is a standard...ess of medications evaluated in,different studies ...
...ome are more likely than their unaffected siblings...h obesity, according to pediatric,researchers. The...er risk,of obesity among children and adults with ...,s Hospital of Philadelphia and the,University of ...udy online,today in the Journal of Pediatrics., T...
Other Medicine Technology:Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 2Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 3Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 4Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting 5Obesity-Related Hormone is Higher in Children with Down Syndrome 2
(Date:11/9/2009)...HENZHEN, China, Nov. 9 /PRNewswire-Asia-FirstCall/...MR ), a leading developer, manufacturer and,market...ts selected unaudited,financial results for the th...09. , , Highlights for Operations as of Septem...s were $151.1 million, an increase of, 3.1% ...
(Date:11/9/2009)...e action backs President Obama,s promise to not ex...mple ,, Bishops still concerned for poor, eld...ire/ -- Cardinal Francis George of Chicago, presid...shops, lauded the November 7 decision of the U.S. ...are reform money from paying for elective abortion...
(Date:11/9/2009)... Studying Genetic Variance Across th...f Genes , (Vocus) Novembe...ies can be extraordinarily valuable when analyzing...enter genetics study that scanned the genomes of...gional differences, Drs. Chao Tian and Michael F. ...
(Date:11/9/2009)...lanted with new cells regained sexual function, st...ay News) -- Researchers were able to restore sexua...ing new penile tissue in the lab and implanting it...tion is a ways off, researchers say the technique ...function in men. , "We were able to show the ti...
(Date:11/9/2009)... Course, to be Offered in April 2010...t , Cambridge, MA (Vocus)...ians for Human Rights (PHR) first inspected a susp..., he realized he would need a team of experts to h...the site properly was a key first step in securing...
Breaking Medicine News(10 mins):Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:News from the November/December Issue of Molecular Medicine 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
...the December issue of Reader,s, Digest and honored...ancer, WOODBURY, Minn., Oct. 31 In honor of brea...t have partnered together for the,first time to cr...tp://www.readersdigest.com/warriors, about a Beau...
...nation to Make-A-Wish Foundation of ... 31 In its 10th annual year of,giving, Starz Ente...ldren,who are living with life-threatening medical...en and their families at the,company,s headquarter...
... Blood Donation, LAKE ZURICH, Ill., Oct. 31 Fenw...nnounced today the names of the 2008,inductees for...ters from,across the United States, the 12 inducte...short supply," said Ron Labrum, president and chie...
...esses were more dangerous if publicized , ...ge greatly influences how people perceive the thre...y. , For example, diseases that receive extensive ... events. When a certain disease receives repeated ...
...a responds to five questions about his health care...sults reveal the politics of back pain and spine t...J (PRWEB) October 31, 2008 -- Senator Barack Obama... -- people who have an intense interest in the sta...
...ience of hormone,balancing vs. hormone replacement...erts who believe that breast cancer and its risks ...biochemist/cancer researcher and co-author,of the ...d with breast cancer stem from an imbalance of hig...
Other Medicine News:Health News:Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Reader's Digest for Exemplifying the Fight Against Breast Cancer 2Health News:Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Reader's Digest for Exemplifying the Fight Against Breast Cancer 3Health News:Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Reader's Digest for Exemplifying the Fight Against Breast Cancer 4Health News:Starz Entertainment Grants Wishes for 13 Colorado Children 2Health News:Starz Entertainment Grants Wishes for 13 Colorado Children 3Health News:Fenwal Names 2008 Inductees for Blood Donation Hall of Fame 2Health News:Media Affects Public Perception of Infectious Diseases 2Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 2Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 3Health News:Natural Hormone Balance: Gaining Ground in the Fight Against Breast Cancer 2
Reciprocating Platelet Shaker TPS-16
...ogesterone is a steroid produced by the adrenal co...ta. As with other steroids, progesterone is synthe...ated steps [1,2]. Progesterone produced by the adr...ed into other steroidogenic pathways, with only a ...
Insulin IRMA Kit
Insulin ELISA Kit
Medicine Products: